Cardiff Oncology Inc (CRDF)
4.17
-0.19
(-4.36%)
USD |
NASDAQ |
Apr 23, 16:00
4.18
+0.01
(+0.24%)
After-Hours: 20:00
Cardiff Oncology Revenue (TTM): 0.488M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.488M |
| September 30, 2023 | 0.46M |
| June 30, 2023 | 0.412M |
| March 31, 2023 | 0.395M |
| December 31, 2022 | 0.386M |
| September 30, 2022 | 0.391M |
| June 30, 2022 | 0.384M |
| March 31, 2022 | 0.361M |
| December 31, 2021 | 0.359M |
| September 30, 2021 | 0.345M |
| June 30, 2021 | 0.395M |
| March 31, 2021 | 0.37M |
| December 31, 2020 | 0.366M |
| September 30, 2020 | 0.3396M |
| June 30, 2020 | 0.2553M |
| March 31, 2020 | 0.2506M |
| December 31, 2019 | 0.2446M |
| September 30, 2019 | 0.2301M |
| June 30, 2019 | 0.2667M |
| March 31, 2019 | 0.3402M |
| December 31, 2018 | 0.3783M |
| September 30, 2018 | 0.4853M |
| June 30, 2018 | 0.5203M |
| March 31, 2018 | 0.5105M |
| December 31, 2017 | 0.5054M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.3885M |
| June 30, 2017 | 0.3542M |
| March 31, 2017 | 0.3556M |
| December 31, 2016 | 0.3811M |
| September 30, 2016 | 0.3922M |
| June 30, 2016 | 0.3604M |
| March 31, 2016 | 0.3155M |
| December 31, 2015 | 0.322M |
| September 30, 2015 | 0.2992M |
| June 30, 2015 | 0.2991M |
| March 31, 2015 | 0.2962M |
| December 31, 2014 | 0.2802M |
| September 30, 2014 | 0.2711M |
| June 30, 2014 | 0.2577M |
| March 31, 2014 | 0.2511M |
| December 31, 2013 | 0.2592M |
| September 30, 2013 | 0.3751M |
| June 30, 2013 | 0.5429M |
| March 31, 2013 | 0.5354M |
| December 31, 2012 | 0.4504M |
| September 30, 2012 | 0.3209M |
| June 30, 2012 | 0.1644M |
| March 31, 2012 | 0.2028M |
| December 31, 2011 | 0.2577M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.2301M
Minimum
Sep 2019
0.488M
Maximum
Dec 2023
0.3526M
Average
0.366M
Median
Dec 2020
Revenue (TTM) Benchmarks
| BioVie Inc | -- |
| Perspective Therapeutics Inc | 0.00 |
| Biolase Inc | 49.16M |
| Tenon Medical Inc | 2.928M |
| Adial Pharmaceuticals Inc | -- |